Article

COPD Maintenance Treatment Gets FDA Approval

Author(s):

Bevespi Aerosphere is a twice-daily, fixed-dose dual bronchodilator combining a long-acting muscarcinic antagonist and a long-acting beta-2 agonist.

The FDA has approved AstraZeneca’s glycopyrrolate and formoterol fumarate (Bevespi Aerosphere) inhalation aerosol for long-term maintenance treatment for patients with chronic obstructive pulmonary disease (COPD).

Bevespi Aerosphere is a twice-daily, fixed-dose dual bronchodilator that combines a long-acting muscarcinic antagonist (LAMA) and a long-acting beta-2 agonist (LABA).

“With the approval of Bevespi Aerosphere we are pleased to provide patients with the first LAMA/LABA in a pressurized metered-dose inhaler, delivered using our unique formulation technology,” said Sean Bohen, executive vice president of the global medicines department and chief medical officer of AstraZeneca, in a press release. “LAMA/LABAs are emerging as a preferred treatment option for many COPD patients. This class aims to provide maximum bronchodilation, which enables patients to breathe better and may help them be more active.”

The FDA based its approval of Bevespi Aerosphere after reviewing the data from the PINNACLE trial, which showed that the product achieved statistically significant improvement in morning pre-dose forced expiratory volume in 1 second at 24 weeks compared with placebo..

The most common adverse reactions observed in patients during trials were urinary tract infection and cough. There were no unexpected safety issues discovered in the study.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Lenacapavir | Image Credit: luchschenF | stock.adobe.com
Doctor diagnosing patient’s health on asthma, lung disease, COVID-19 or bone cancer illness with radiological chest x-ray film for medical healthcare hospital service - Image credit: Chinnapong | stock.adobe.com
Adult and child hands holding lung, world tuberculosis tb day, world no tobacco day, lung cancer, long covid, COPD, eco air pollution, organ donation concept - Image credit: SewcreamStudio | stock.adobe.com
Asthma COPD Breath Nebulizer And Mask Given By Doctor Or Nurse - Image credit: Angelov | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Image credit: AwieDarwis | stock.adobe.com
Image credit: viperagp | stock.adobe.com
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com